{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:25:29Z","timestamp":1738992329117,"version":"3.37.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T00:00:00Z","timestamp":1072742400000},"content-version":"vor","delay-in-days":697,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1053\/jhep.2002.31607","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"258-262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis"],"prefix":"10.1097","volume":"35","author":[{"given":"Anthony E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1053\/jhep.2002.31607-BIB1|cit1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0528.2002.017410.x","article-title":"The peculiar autoimmunity of primary biliary cirrhosis","volume":"174","author":"Mackay","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1053\/jhep.2002.31607-BIB2|cit2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2362.2001.00765.x","article-title":"Immuno-pathogenesis of cholestatic autoimmune liver diseases","volume":"31","author":"Medina","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/jhep.2002.31607-BIB3|cit3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2001.23902","article-title":"Molecular mimicry and primary biliary cirrhosis: premises not promises","volume":"33","author":"Van de Water","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of primary biliary cirrhosis","volume":"458","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.31607-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.31607-BIB6|cit6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/gut.37.3.301","article-title":"The ursodeoxycholic acid story in primary biliary cirrhosis","volume":"37","author":"Lim","year":"1995","journal-title":"Gut"},{"key":"10.1053\/jhep.2002.31607-BIB7|cit7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-1007190","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis","volume":"17","author":"Combes","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1053\/jhep.2002.31607-BIB8|cit8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB9|cit9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1440-1746.1998.tb00707.x","article-title":"From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament","volume":"13","author":"Makino","year":"1998","journal-title":"J Gastroent Hepatol"},{"key":"10.1053\/jhep.2002.31607-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0016-5085(93)90672-Y","article-title":"Hepatoprotective properties of ursodeoxycholic acid","volume":"104","author":"Heuman","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.31607-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0016-5085(92)90781-S","article-title":"Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy","volume":"102","author":"Perdigoto","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.31607-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.31607-BIB13|cit13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007191","article-title":"The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis","volume":"17","author":"Kaplan","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1053\/jhep.2002.31607-BIB14|cit14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid","volume":"18","author":"Buscher","year":"1993","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.31607-BIB15|cit15","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB16|cit16","first-page":"295","article-title":"Pilot study of low dose methotrexate treatment for primary biliary cirrhosis","volume":"91","author":"Bergasa","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/jhep.2002.31607-BIB17|cit17","doi-asserted-by":"crossref","first-page":"124A","DOI":"10.1016\/0270-9139(95)94219-X","article-title":"Methotrexate therapy of primary biliary cirrhosis: 2 yr study comparing two doses [Abstract]","volume":"22","author":"Conjeevaram","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB18|cit18","first-page":"A1406","article-title":"Methotrexate therapy in primary biliary cirrhosis is of limited efficacy and accompanied by serious side effects [Abstract]","volume":"112","author":"Vandeputter","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.31607-BIB19|cit19","first-page":"248A","article-title":"Low-dose methotrexate in primary biliary cirrhosis. Long-term results of a placebo-controlled trial [Abstract]","volume":"26","author":"Hendrickse","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB20|cit20","first-page":"545A","article-title":"Methotrexate therapy for primary biliary cirrhosis: five year follow up [Abstract]","volume":"28","author":"Bach","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB21|cit21","first-page":"392A","article-title":"Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol [Abstract]","volume":"28","author":"Munoz","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB22|cit22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB23|cit23","first-page":"227","article-title":"The late results of long-term treatment of primary biliary cirrhosis by corticosteroids","volume":"16","author":"Howat","year":"1966","journal-title":"Rev Internat Hepatol"},{"key":"10.1053\/jhep.2002.31607-BIB24|cit24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1053\/jhep.2002.31607-BIB25|cit25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1053\/jhep.2002.31607-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(75)92661-6","article-title":"Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de novo purine synthesis in lymphocyte transformation","volume":"2","author":"Allison","year":"1975","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.31607-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.31607-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/clinchem\/43.12.2312","article-title":"IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide","volume":"43","author":"Griesmacher","year":"1997","journal-title":"Clin Chem"},{"key":"10.1053\/jhep.2002.31607-BIB29|cit29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7164\/antibiotics.22.358","article-title":"Immunosuppressive effect of mycophenolic acid","volume":"22","author":"Mitsui","year":"1969","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1053\/jhep.2002.31607-BIB30|cit30","first-page":"2923","article-title":"Antitumor and immunosuppressive effects of mycophenolic acid derivatives","volume":"36","author":"Ohsugi","year":"1976","journal-title":"Cancer Res"},{"key":"10.1053\/jhep.2002.31607-BIB31|cit31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0190-9622(79)80097-3","article-title":"Efficacy of mycophenolic acid for the treatment of psoriasis","volume":"1","author":"Gomez","year":"1979","journal-title":"J Amer Acad Derm"},{"key":"10.1053\/jhep.2002.31607-BIB32|cit32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","article-title":"Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy and safety","volume":"17","author":"Epinette","year":"1987","journal-title":"J Amer Acad Derm"},{"key":"10.1053\/jhep.2002.31607-BIB33|cit33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J Clin Pharm"},{"key":"10.1053\/jhep.2002.31607-BIB34|cit34","first-page":"925","article-title":"Pharmacokinetics of mycophenolate mofetil (RS61443): a short review","volume":"28","author":"Bullingham","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1053\/jhep.2002.31607-BIB35|cit35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/jhep.2002.31607-BIB36|cit36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1399-0012.1996.tb00652.x","article-title":"From mice to man: the preclinical history of mycophenolate mofetil","volume":"10","author":"Sollinger","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1053\/jhep.2002.31607-BIB37|cit37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(95)92775-1","article-title":"Mycophenolate mofetil for transplantation: new drug, old problems?","volume":"346","author":"Gray","year":"1995","journal-title":"Lancet"},{"issue":"Suppl 8","key":"10.1053\/jhep.2002.31607-BIB38|cit38","first-page":"S117","article-title":"Therapy of rheumatoid arthritis with mycophenolate mofetil","volume":"11","author":"Goldblum","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/jhep.2002.31607-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(05)76240-1","article-title":"Mycophenolate mofetil in IBD patients","volume":"354","author":"Radford-Smith","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.31607-BIB40|cit40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/77444","article-title":"Taking aim at HIV replication","volume":"6","author":"Finzi","year":"2000","journal-title":"Nat Med"},{"key":"10.1053\/jhep.2002.31607-BIB41|cit41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat Med"},{"key":"10.1053\/jhep.2002.31607-BIB42|cit42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.38.1.126","article-title":"Effect of mycophenolic acid on Epstein-Barr virus infection of human lymphocytes","volume":"38","author":"Alfieri","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/jhep.2002.31607-BIB43|cit43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajhp\/54.3.285","article-title":"Mycophenolate mofetil: a unique immunosuppressive agent","volume":"54","author":"Hood","year":"1997","journal-title":"Amer J Health-System Pharm"},{"key":"10.1053\/jhep.2002.31607-BIB44|cit44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(97)70147-6","article-title":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses","volume":"37","author":"Silverman Kitchin","year":"1997","journal-title":"J Amer Acad Dermatol"},{"key":"10.1053\/jhep.2002.31607-BIB45|cit45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00007890-199801270-00025","article-title":"Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat","volume":"65","author":"Dissanayake","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/jhep.2002.31607-BIB46|cit46","first-page":"319","volume-title":"Immunosuppressive and Antiinflammatory Drugs","volume":"696","author":"Jones","year":"1993"},{"key":"10.1053\/jhep.2002.31607-BIB47|cit47","first-page":"1165","article-title":"Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis","volume":"11","author":"Jones","year":"1999","journal-title":"Eur J Gastrenterol Hepatol"},{"key":"10.1053\/jhep.2002.31607-BIB48|cit48","first-page":"203","volume-title":"Immunology and the Liver: Autoimmunity","author":"Jones","year":"2000"},{"key":"10.1053\/jhep.2002.31607-BIB49|cit49","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep.1840140316","article-title":"Accurate prediction of death by serial determinations of galactose elimination capacity in primary biliary cirrhosis: A comparison with the Mayo model","volume":"14","author":"Reichen","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.31607-BIB50|cit50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/j.1552-4604.1996.tb04209.x","article-title":"Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with varying degrees of hepatic oxidative impairment","volume":"36","author":"Parker","year":"1996","journal-title":"J Clin Pharm"},{"key":"10.1053\/jhep.2002.31607-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.31607","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.31607","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200202000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:47:21Z","timestamp":1738943241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200202000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1053\/jhep.2002.31607","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}